AI is one of the major technological breakthroughs that is transforming every business sector around the globe. AI in pharmaceutical industry refers to the system of interconnected and automated technologies which can function autonomously, requiring very little or no human interventions. AI analyzes the colossal amount of data by using techniques such as machine learning, deep learning, natural language processing, adaptive learning, and computer vision. Pharmaceutical and biopharmaceutical companies are leveraging AI for various applications including drug discovery, drug development, and drug commercialization. Global AI (artificial intelligence) in pharmaceutical market is expected to escalate at an impressive growth rate over the forecast period. The report analyzes the market on the basis of deployment type, application, end-user, and regions.

On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to hold the dominating position over the forecast period due to the presence of key AI technology providers and extensive adoption of AI technologies across the region. Moreover, well-developed healthcare infrastructure across the region is also expected to augment the adoption of AI technologies in pharmaceutical and biopharmaceutical companies. Europe is expected to grow at a significant growth rate over the forecast period 2019–2025. The growth of European AI in pharmaceutical market is backed by the presence of key pharmaceutical and biopharmaceutical companies, such as F. Hoffmann La-Roche AG and Merck KGaA, which are adopting AI for drug discovery, drug development, and drug commercialization.

Furthermore, the global AI (artificial intelligence) in pharmaceutical market consists of a number of market players which are providing AI technology to cater to a wide range of biopharmaceutical and pharmaceutical companies. Some of the key market players include Google LLC, Microsoft Corp., IBM Corp., AiCure, LLC., Cyclica and so on. These players adopt various strategies in order to remain competitive in the global market. Some of the strategies followed by market players include mergers and acquisitions, product offering expansion, geographical expansion, and partnerships and collaborations. A significant number of partnerships and collaborations have been observed in the global AI (artificial intelligence) in pharmaceutical market in recent years. For instance, in November 2018, Cyclica collaborated with Bayer AG to advance drug discovery by harnessing AI technologies. Moreover, in October 2018, Chinese tech giant Tencent Holdings partnered with UK-based Medopad Ltd. This partnership aimed to build AI algorithms that are capable of remotely monitoring patients with Parkinson’s disease (PD).

Research Methodology

The market study of the global AI (artificial intelligence) in pharmaceutical market is incorporated by extensive primary and secondary research conducted by a research team at OMR.  Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include

• Financial reports of companies involved in the market
  
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog

The report is intended for pharmaceutical companies, biopharmaceutical companies, research institutes, market research firms, investment companies, third-party service providers, AI system providers, system integrators, cloud service providers for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation

• Global AI (Artificial Intelligence) in Pharmaceutical Market Research and Analysis by Deployment Type
  
• Global AI (Artificial Intelligence) in Pharmaceutical Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the global AI (artificial intelligence) in pharmaceutical
  
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global AI (artificial intelligence) in pharmaceutical market.
• Insights about market determinants which are stimulating the global AI (artificial intelligence) in pharmaceutical.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.